SEC Comment Letter 0000000000-24-006612 to Ultragenyx Pharmaceutical Inc. (RARE) (CIK 0001515673) (RARE)
Ultragenyx Pharmaceutical Inc. (RARE) (CIK 0001515673)
Date: June 10, 2024 · CIK: 0001515673 · Accession: 0000000000-24-006612
AI Filing Summary & Sentiment
Letter
United States securities and exchange commission logo June 10, 2024 Howard Horn Executive Vice President Ultragenyx Pharmaceutical Inc. 60 Leveroni Court Novato, CA 94949 Re:Ultragenyx Pharmaceutical Inc. Form 10-K for Fiscal Year Ended December 31, 2023 File No. 1-36276 Dear Howard Horn: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences
Show Raw Text
United States securities and exchange commission logo
June 10, 2024
Howard Horn
Executive Vice President
Ultragenyx Pharmaceutical Inc.
60 Leveroni Court
Novato, CA 94949
Re:Ultragenyx Pharmaceutical Inc.
Form 10-K for Fiscal Year Ended December 31, 2023
File No. 1-36276
Dear Howard Horn:
We have completed our review of your filing. We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences